摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(chloromethyl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate | 1445394-31-9

中文名称
——
中文别名
——
英文名称
[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(chloromethyl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
英文别名
——
[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(chloromethyl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate化学式
CAS
1445394-31-9
化学式
C20H30ClFN3O13P
mdl
——
分子量
605.896
InChiKey
UELNLVWBBJJGPL-UIVXKWKOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    39
  • 可旋转键数:
    17
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    204
  • 氢给体数:
    2
  • 氢受体数:
    14

文献信息

  • SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
    申请人:Alios BioPharma, Inc.
    公开号:US20130165400A1
    公开(公告)日:2013-06-27
    Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.
    本文披露了核苷、核苷酸及其类似物,包括一个或多个核苷、核苷酸及其类似物的药物组合物,以及它们的合成方法。本文还披露了使用核苷、核苷酸和其类似物来改善和/或治疗疾病和/或病况的方法,包括使用核苷、核苷酸和其类似物来治疗副粘病毒和/或正粘病毒感染的方法。
  • [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES, NUCLÉOTIDES SUBSTITUÉS ET LEURS ANALOGUES
    申请人:ALIOS BIOPHARMA INC
    公开号:WO2014209979A1
    公开(公告)日:2014-12-31
    Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a norovirus, with a nucleoside, a nucleotide and an analog thereof.
    本文揭示了核苷、核苷酸及其类似物,包括一个或多个核苷、核苷酸及其类似物的药物组合物,以及它们的合成方法。本文还揭示了利用核苷、核苷酸及其类似物改善和/或治疗疾病和/或病况的方法,包括使用核苷、核苷酸和其类似物治疗诺如病毒感染的方法。
  • [EN] COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS<br/>[FR] POLYTHÉRAPIE POUR TRAITER UN PARAMYXOVIRUS
    申请人:ALIOS BIOPHARMA INC
    公开号:WO2016022464A1
    公开(公告)日:2016-02-11
    Disclosed herein are a combination of compounds and methods of using the combination compounds for ameliorating, treating and/or preventing a paramyxovirus viral infection.
    本文披露了一种化合物组合以及使用该化合物组合来改善、治疗和/或预防副黏病毒感染的方法。
  • [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES, NUCLÉOTIDES SUBSTITUÉS ET ANALOGUES DE CEUX-CI
    申请人:ALIOS BIOPHARMA INC
    公开号:WO2013142525A1
    公开(公告)日:2013-09-26
    Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.
    本文披露了核苷、核苷酸及其类似物,包括一个或多个核苷、核苷酸及其类似物的制药组合物,以及其合成方法。本文还披露了使用核苷、核苷酸和其类似物改善和/或治疗疾病和/或病况的方法,包括从副黏病毒和/或正黏病毒感染中治疗。
  • [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES SUBSTITUÉS, NUCLÉOTIDES SUBSTITUÉS ET ANALOGUES DE CEUX-CI
    申请人:ALIOS BIOPHARMA INC
    公开号:WO2013096679A1
    公开(公告)日:2013-06-27
    Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.
    本文披露了核苷、核苷酸及其类似物,包括一个或多个核苷、核苷酸及其类似物的制药组合物,以及其合成方法。本文还披露了使用核苷、核苷酸和其类似物来改善和/或治疗疾病和/或病况的方法,包括来自副黏病毒和/或正黏病毒的感染。
查看更多